Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Management of Hemoglobin A1c Levels

Clinical Interpretation and Risk Assessment

  • The American Diabetes Association defines an HbA1c level of 5.5% as within the normal glycemic range, corresponding to an estimated average blood glucose of approximately 111 mg/dL over the previous 2-3 months, indicating normal glucose metabolism 1
  • Prediabetes is defined as HbA1c between 5.7-6.4%, and diabetes is diagnosed at HbA1c ≥6.5%, according to clinical guidelines 2, 3
  • Risk stratification should consider factors beyond HbA1c, including family history of diabetes, body mass index (BMI) and waist circumference, physical activity level, and presence of other cardiovascular risk factors 1, 4
  • The American College of Physicians recommends no pharmacologic therapy for individuals with an HbA1c of 5.5%, instead focusing on preventive lifestyle measures such as maintaining a healthy weight, regular physical activity, and a balanced diet 5, 2
  • Routine follow-up HbA1c testing every 1-3 years is appropriate for individuals with normal HbA1c values, with more frequent monitoring warranted if other risk factors for diabetes are present 2, 4

Special Considerations

  • The American College of Obstetricians and Gynecologists notes that in pregnancy, different HbA1c targets apply, highlighting the need for individualized care 6

Common Pitfalls to Avoid

  • The American Diabetes Association advises against overtreatment of an HbA1c of 5.5%, as this could lead to unnecessary medication exposure and potential hypoglycemia, and emphasizes the importance of lifestyle optimization for long-term metabolic health 5, 2, 4